SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about board meeting

24 Feb 2018 Evaluate

Orchid Pharma has informed about the board meeting to be held on march 02, 2018 - to consider and approve the unaudited financial results for the quarter ended June 30, 2017.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

1051.80 44.35 (4.40%)
14-Jul-2026 11:37 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1933.95
Dr. Reddys Labs. 1242.60
Cipla 1450.00
Zydus Lifesciences 1150.90
Lupin 2492.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: